StocksMedium•5 November 2026•
1 min read
Vir Biotechnology Reports $0.57 Per Share Loss in Third Quarter
Key Facts
1Vir Biotechnology reported a quarterly loss of $0.57 per share.
2The current quarter's loss is an improvement compared to the $1.17 per share loss reported a year ago.
Vir Biotechnology reported a quarterly loss of $0.57 per share for the third quarter of 2026. Zacks reported that this loss represents an improvement from the $1.17 per share loss recorded by the company a year ago, even as the firm missed revenue expectations for the period.
The stock VIR closed at $11.77 on November 4, 2026, after trading between a session low of $11.17 and a high of $11.81. These financial results were released as part of the company's standard Q3 fiscal reporting cycle.